University of Miami / Jackson Memorial Hospital
Welcome,         Profile    Billing    Logout  
 17 Trials 
39 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Mitchell, Charles D
STOMP, NCT05534984: Study of Tecovirimat for Human Mpox Virus

Active, not recruiting
3
719
Japan, US, RoW
Tecovirimat Oral Capsule, Placebo, Tecovirimat Oral Capsule (Open Label)
National Institute of Allergy and Infectious Diseases (NIAID), SIGA Technologies
MPOX
10/24
09/25
NCT05674656 / 2022-000829-24: Pharmacokinetics, Safety, Tolerability of Dolutegravir/Rilpivirine in Pediatrics

Recruiting
1/2
20
US
Dolutegravir/Rilpivirine FDC, JULUCA
ViiV Healthcare, Janssen Research & Development, LLC
HIV Infections
06/26
05/28
NCT05154513: Long-Term Clinical, Immunologic, and Virologic Profiles of Children Who Received Early Treatment for HIV

Recruiting
N/A
250
US, RoW
Cohort 1
International Maternal Pediatric Adolescent AIDS Clinical Trials Group, National Institute of Allergy and Infectious Diseases (NIAID), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institute of Mental Health (NIMH)
HIV Infection
11/27
11/27
Patel, Amit N
MATINEE, NCT04133909 / 2018-001540-56: Mepolizumab as Add-on Treatment IN Participants With COPD Characterized by Frequent Exacerbations and Eosinophil Level

Jan 2024 - Dec 2024: Acceptance of regulatory submission in US (based on MATINEE trial) for COPD
Jan 2024 - Dec 2024: Acceptance of regulatory submission in EU (based on MATINEE trial) for COPD
Jan 2024 - Dec 2024: Data from MATINEE trial for COPD
Jan 2024 - Dec 2024: Acceptance of regulatory submission in China (based on MATINEE trial) for COPD
Hourglass Jul 2024 - Dec 2024 : Regulatory decision in Japan for COPD
Completed
3
806
Europe, Canada, US, RoW
Placebo, Mepolizumab
GlaxoSmithKline, PPD DEVELOPMENT, LP
Pulmonary Disease, Chronic Obstructive
08/24
08/24
NIMBLE, NCT04718389 / 2020-003612-28: A Study of GSK3511294 (Depemokimab) Compared With Mepolizumab or Benralizumab in Participants With Severe Asthma With an Eosinophilic Phenotype

Hourglass Feb 2024 - Jun 2024 : Acceptance of regulatory submission in China for CRSwNP
Active, not recruiting
3
1667
Europe, Canada, Japan, US, RoW
GSK3511294 (Depemokimab), Mepolizumab, Benralizumab, Placebo, Standard of care (SoC), Pre-filled Syringes (PFS)
GlaxoSmithKline, Iqvia Pty Ltd
Asthma
10/25
10/25
REMAP-CAP, NCT02735707 / 2015-002340-14: Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia

Recruiting
3
20000
Europe, Canada, Japan, US, RoW
Ceftriaxone, Moxifloxacin or Levofloxacin, Piperacillin-tazobactam, Ceftaroline, Amoxicillin-clavulanate, Standard course macrolide, Extended course macrolide, No systemic corticosteroid, Fixed-duration Hydrocortisone, Shock-dependent hydrocortisone, Fixed-duration higher dose Hydrocortisone, No antiviral agent for influenza, Five-days oseltamivir, Ten-days oseltamivir, No antiviral agent for COVID-19, Lopinavir / Ritonavir, Hydroxychloroquine, Hydroxychloroquine + lopinavir/ritonavir, Ivermectin, No immune modulation for COVID-19, Interferon beta-1a, IFN-β1a, Anakinra, Tocilizumab, Sarilumab, Local standard venous thromboprophylaxis, Therapeutic dose anticoagulation, Conventional low dose thromboprophylaxis, Intermediate dose thromboprophylaxis, Continuation of therapeutic dose anticoagulation, No immunoglobulin, Convalescent plasma, Delayed administration of convalescent plasma, No vitamin C, Vitamin C, No antiplatelet, Aspirin, acetylsalicylic acid, P2Y12 inhibitor, Clopidogrel, Prasugrel, Ticagrelor, No simvastatin, Simvastatin, Eritoran, Apremilast, Clinician-preferred mechanical ventilation strategy, Protocolised mechanical ventilation strategy, No renin-angiotensin system inhibitor, Angiotensin converting enzyme inhibitor, Ramipril, Lisinopril, Perindopril, Enalapril, Trandolapril, Captopril, Angiotensin Receptor Blockers, Losartan, Valsartan, Candesartan, Irbesartan, Telmisartan, Olmesartan, ARB + DMX-200, No cysteamine, Cysteamine, Fixed-duration dexamethasone, Baloxavir Marboxil, Five-days oseltamivir + baloxavir marboxil, Ten-days oseltamivir + baloxavir marboxil, No endothelial modulator, Imatinib, No Immune Modulator for Influenza, Baricitinib, Nirmatrelvir/ritonavir, Paxlovid, Remdesivir, Nirmatrelvir/ritonavir + remdesivir
UMC Utrecht, Australian and New Zealand Intensive Care Research Centre, Medical Research Institute of New Zealand, Unity Health, Berry Consultants, Global Coalition for Adaptive Research, University of Pittsburgh Medical Center, Intensive Care National Audit & Research Centre, St. Marianna University School of Medicine, Nat Intensive Care Surveillance - MORU, National University Hospital, Singapore
Community-acquired Pneumonia, Influenza, COVID-19
02/26
02/28
ALL-RIC, NCT03821610 / 2017-004800-23: A Comparison of Reduced Dose Total Body Irradiation (TBI) and Cyclophosphamide With Fludarabine and Melphalan Reduced Intensity Conditioning in Adults With Acute Lymphoblastic Leukaemia (ALL) in Complete Remission.

Active, not recruiting
2
242
Europe
Fludarabine, Melphalan, Alemtuzumab, Cyclophosphamide, Mesna, Total Body Irradiation (8Gy)
University of Birmingham
Acute Lymphoblastic Leukemia
11/24
11/27
PRESERVE, NCT04972097: Pivotal Study of the NanoKnife System for the Ablation of Prostate Tissue

Active, not recruiting
N/A
121
US
Irreversible Electroporation, The NanoKnife System
Angiodynamics, Inc.
Prostate Cancer
07/24
07/24
ASPIRE PH, NCT04555161: Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System

Recruiting
N/A
30
US
Aria CV Pulmonary Hypertension System, Aria CV PH System
Aria CV, Inc
Pulmonary Arterial Hypertension, Pulmonary Hypertension, Right Heart Dysfunction
10/25
10/26
NCT03988309: STRATA: Safe Testing of Risk for AsymptomaTic MicrohematuriA

Active, not recruiting
N/A
554
Canada, US
Cxbladder
Pacific Edge Limited
Hematuria, Urothelial Carcinoma
12/24
12/24
NCT03970343: Post Approval Study (PAS) of the OPTIMIZER Smart and CCM Therapy

Recruiting
N/A
620
US
OPTIMIZER Smart System
Impulse Dynamics
Heart Failure
03/26
03/26
Peterson, Eric D
STAR, NCT04994756: Stroke Thrombectomy and Aneurysm Registry

Recruiting
N/A
40000
Europe, Canada, Japan, US, RoW
Stroke/Thrombectomy/Aneurysm-specific surgical procedures
Medical University of South Carolina
Stroke, Thromboses, Intracranial, Aneurysm, Brain
01/55
01/55
Starke, Robert M
NCT04141020: Effect of Sirolimus on Molecular Alterations in Cerebral Aneurysms

Recruiting
2
80
US
Microsurgical clipping, Endovascular treatment, Sirolimus, Rapamune
University of Miami, National Institute of Neurological Disorders and Stroke (NINDS)
Cerebral Aneurysm
11/26
11/26
NCT05436470: Treatment (Compassionate) Use of Device - PK Papyrus

Temporarily Not Available
N/A
US
PK Papyrus
University of Miami
Pseudoaneurysm, Carotid, Pseudoaneurysm
 
 
RESCUE-ICAS, NCT05403593: Registry of Emergent Large VeSsel OCclUsion DuE to IntraCranial AtherosclerosiS

Completed
N/A
600
Europe, US, RoW
No Intervention
Medical University of South Carolina, University of Göttingen, Thomas Jefferson University, University of Miami, University of Basel, University of Tennessee, Wake Forest University Health Sciences, Emory University, The University of Texas Health Science Center at San Antonio, University of Iowa, Indiana University, University of Chicago, Careggi Hospital, Massachusetts General Hospital, Imam Abdulrahman Bin Faisal University, Brown University, Yale University, Sutter Health, Centro Hospitalar de Lisboa Central, HCA Houston Healthcare Kingwood, advocate christ medical center
Intracranial Stenosis, Large Vessel Occlusion, Mechanical Thrombectomy
03/24
06/24
VANTAGE, NCT04391803: EvaLuate EndoVascular Treatment of Acutely Ruptured Shallow Intradural Aneurysms with the Pipeline™ Flex Embolization Device with Shield TEchnology™ (ELEVATE)

Recruiting
N/A
200
NA
Pipeline™ Flex Embolization Device with Shield Technology™, Pipeline™ Shield Device
Medtronic Neurovascular Clinical Affairs
Intracranial Aneurysm, Ruptured Aneurysm
01/26
01/27
NCT04129125: The Imperative Trial: Treatment of Acute Ischemic Stroke With the Zoom Reperfusion System

Completed
N/A
328
US
Zoom Reperfusion System
Imperative Care, Inc.
Ischemic Stroke, Acute Stroke
05/24
05/24
EMBOLISE, NCT04402632: Embolization of the Middle Meningeal Artery with ONYX™ Liquid Embolic System for Subacute and Chronic Subdural Hematoma

Active, not recruiting
N/A
600
US
Surgical Management, Surgical Management + Treatment, No Treatment, Treatment
Medtronic Neurovascular Clinical Affairs
Subdural Hematoma
12/24
03/25
CHESS, NCT06347796: Chronic Subdural Hematoma Treatment With Embolization Versus Surgery Study

Recruiting
N/A
520
US
Conventional Surgery, Middle Meningeal Artery Embolization (MMAE)
The University of Texas Medical Branch, Galveston, National Institute of Neurological Disorders and Stroke (NINDS)
Chronic Subdural Hematoma
09/28
09/28
NCT03814850: Remote Ischemic PreConditioning (RIPC)

Withdrawn
N/A
50
US
Standard Manual Aneroid Sphygmomanometer
Sebastian Koch
Unruptured Cerebral Aneurysm
12/25
12/25
NCT04057352: Citadel Embolization Device Study

Recruiting
N/A
150
US
Citadel Embolization Device
Stryker Neurovascular
Unruptured Wide-neck Aneurysms
06/26
06/26
TESTED, NCT05911568: Treatment With Endovascular Intervention for STroke Patients With Existing Disability

Recruiting
N/A
1060
US
Endovascular Stroke Treatment, Medical Management
University of Cincinnati, Patient-Centered Outcomes Research Institute, University of California, Los Angeles, Icahn School of Medicine at Mount Sinai
Stroke, Stroke, Acute, Stroke, Ischemic
01/28
04/28
STAR, NCT04994756: Stroke Thrombectomy and Aneurysm Registry

Recruiting
N/A
40000
Europe, Canada, Japan, US, RoW
Stroke/Thrombectomy/Aneurysm-specific surgical procedures
Medical University of South Carolina
Stroke, Thromboses, Intracranial, Aneurysm, Brain
01/55
01/55
Chaparro, Sandra
DETECT-HF, NCT06378632: AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEM

Recruiting
N/A
500
Europe, US, RoW
Hearo App
Cordio Medical
Heart Failure
01/25
03/25
PROACTIVE-HF, NCT04089059: IDE Trial Heart Failure NYHA Class III

Active, not recruiting
N/A
457
Europe, US
Cordella™ Pulmonary Artery Sensor System
Endotronix, Inc.
Heart Failure NYHA Class III
04/28
04/28
NCT05934487: PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III

Recruiting
N/A
1650
US
Cordella™ Pulmonary Artery Sensor System
Endotronix, Inc.
Heart Failure NYHA Class II, Heart Failure NYHA Class III
09/27
09/29
Hershberger, Ray
NCT03037632: DCM Precision Medicine Study

Active, not recruiting
N/A
6500
US
Family Heart Talk Booklet
Ray Hershberger, National Heart, Lung, and Blood Institute (NHLBI), National Human Genome Research Institute (NHGRI)
Idiopathic Dilated Cardiomyopathy
04/24
04/24
NCT04638621: Dilated Cardiomyopathy-Cardiac Magnetic Resonance (DCM-CMR) Ancillary Study

Recruiting
N/A
650
US
Ohio State University, National Heart, Lung, and Blood Institute (NHLBI)
Dilated Cardiomyopathy
01/26
04/26
Hudson, Laura
INTEGRA-D, NCT05855135: Assessment of Combined CCM and ICD Device in HFrEF

Recruiting
N/A
300
US
OPTIMIZER® Integra CCM-D System (Treatment Arm)
Impulse Dynamics
Heart Failure, Heart Failure with Reduced Ejection Fraction, Implantable Defibrillator User, CCM Therapy, Non-ischemic Cardiomyopathy, Ischemic Cardiomyopathy, Sudden Cardiac Arrest, Arrhythmias, Cardiac, Ventricular Tachycardia, Ventricular Fibrillation
06/25
12/25
AIM HIGHer, NCT05064709: Assessment of CCM in HF with Higher Ejection Fraction

Recruiting
N/A
1500
US
Cardiac Contractility Modulation Therapy via OPTIMIZER™ Smart Mini System, CCM Group (CCM ON), OPTIMIZER™ Smart Mini System, Sham Group (CCM OFF)
Impulse Dynamics
Heart Failure, Heart Failure with Preserved Ejection Fraction, Heart Failure with Mid Range Ejection Fraction, Heart Failure with Moderately Reduced Ejection Fraction, Diastolic Heart Failure
02/25
02/26
Pereira, Lutecia
NCT05296070: Open-label of Loncastuximab Tesirine (ADCT-402) in Relapsed/Refractory Marginal Zone Lymphoma

Recruiting
2
50
US
Loncastuximab tesirine 150 µg/Kg, Loncastuximab tesirine 75µg/Kg
University of Miami, ADC Therapeutics S.A.
Marginal Zone Lymphoma
06/28
06/29
Tenser, Matthew
SISTER, NCT05948566: Strategy for Improving Stroke Treatment Response

Recruiting
2
300
US
TS23
Translational Sciences, Inc., University of Cincinnati, National Institute of Neurological Disorders and Stroke (NINDS), Medical University of South Carolina, University of Arizona
Ischemic Stroke
07/27
12/27
NCT04129125: The Imperative Trial: Treatment of Acute Ischemic Stroke With the Zoom Reperfusion System

Completed
N/A
328
US
Zoom Reperfusion System
Imperative Care, Inc.
Ischemic Stroke, Acute Stroke
05/24
05/24
Abdelsalam, Ahmed Y
NCT04572503: Modified Anterior Palatoplasty In Obstructive Sleep Apnea Syndrome

Recruiting
N/A
20
RoW
Barbed Suture Modified Anterior Palatoplasty
Benha University
Obstructive Sleep Apnea
12/25
03/26
NCT04129125: The Imperative Trial: Treatment of Acute Ischemic Stroke With the Zoom Reperfusion System

Completed
N/A
328
US
Zoom Reperfusion System
Imperative Care, Inc.
Ischemic Stroke, Acute Stroke
05/24
05/24
NCT04684329: Serum Esnophilic Cationic Protein Level as Diagnostic Marker in Cow Milk Protein Allergy Infants

Not yet recruiting
N/A
84
RoW
Assiut University
Cow Milk Allergy
01/22
03/22
Doblecki-Lewis, Susanne
STOMP, NCT05534984: Study of Tecovirimat for Human Mpox Virus

Active, not recruiting
3
719
Japan, US, RoW
Tecovirimat Oral Capsule, Placebo, Tecovirimat Oral Capsule (Open Label)
National Institute of Allergy and Infectious Diseases (NIAID), SIGA Technologies
MPOX
10/24
09/25
DEPTH, NCT05382208: Doxycycline for Emphysema in People Living With HIV (The Trial)

Recruiting
2
250
US
Doxycycline, Placebo
Weill Medical College of Cornell University, National Heart, Lung, and Blood Institute (NHLBI), University of California, Los Angeles, University of Iowa, University of Michigan
Emphysema, HIV
02/27
02/27
PCORI PrEP, NCT04855773: Comparing Mobile Health Strategies to Improve Pre-exposure Prophylaxis Use (PrEP) for HIV Prevention

Recruiting
N/A
300
US
PrEPmate, Dot Diary
Public Health Foundation Enterprises, Inc., Patient-Centered Outcomes Research Institute, University of California, San Francisco, University of Miami, Whitman-Walker Health, San Francisco AIDS Foundation, WelTel, San Francisco Department of Public Health
HIV Infections, Sexually Transmitted Diseases
08/23
08/23

Download Options